Biologic

Biologic initiation in children hospitalized with new-onset systemic juvenile idiopathic arthritis increased significantly from 2008 to 2019, reaching 40% between 2017 and 2019, and may be linked with reduced glucocorticoid use, according to data.

Three strategies aimed at starting patients with polyarticular juvenile idiopathic arthritis on different combinations of DMARDs and biologics resulted in similar rates of clinically inactive disease without glucocorticoids at 12 months, according to data.

The U.S. Supreme Court has denied a petition from Novartis’ Sandoz to review an earlier U.S. appeals court ruling in favor of Amgen’s etanercept against etanercept-szzs, effectively blocking the biosimilar from entering the U.S. market.

While glucocorticoids are a “real problem” in causing infections among patients with rheumatic and autoimmune diseases, complications linked to biologics should be on the radar for rheumatologists as well, according to a speaker here.

A greater percentage of patients with psoriatic arthritis achieve remission with biologic therapy than those with rheumatoid arthritis, at both 1- and 12-year follow-up, according to data published in Arthritis Research & Therapy.

Biologic therapy exposure within 60 days of inflammatory bowel disease-related surgery did not confer a risk for post-operative infectious or surgical site complications, according to research presented at the Crohn’s and Colitis Congress.

Treating psoriasis and psoriatic disease during the COVID-19 pandemic has proven to be challenging for many providers.

The emergence of novel therapies over the last decade has turned the treatment of rheumatoid arthritis upside down.

AUSTIN, Texas — Approximately 30% of patients with inflammatory bowel disease developed new or worsening extraintestinal manifestations after receiving Entyvio, according to data presented at Crohn’s & Colitis Congress extraintestinal manifestations.

KOLOA, Hawaii — At Orthopedics Today Hawaii, Anthony A. Romeo, MD, highlighted important topics for orthopedic surgeons discussed at the meeting, such as sports medicine, trauma, total joint replacement, shoulder and elbow, and practice management.